@misc{indiciaefc947b9616dc,
  title = {The CIpP activator, TR-57, is highly effective as a single agent and in combination with venetoclax against CLL cells in vitro.},
  author = {Fatima, N. and Shen, Y. and Crassini, K. and Iwanowicz, E. and Lang, H. and Karanewsky, D. and Christopherson, R. and Mulligan, S. and Best, G.},
  year = {2022},
  doi = {10.1101/2022.03.07.483345},
  url = {https://www.biorxiv.org/content/10.1101/2022.03.07.483345v1},
  note = {Source identifier: 10.1101/2022.03.07.483345}
}